SALTER LABS INFANT NASAL CPAP CANNULA— 510(k) K912434

Substantially Equivalent

Salter Labs

FDA 510(k) clearance K912434 for SALTER LABS INFANT NASAL CPAP CANNULA, Substantially Equivalent on 1991-07-30. Applicant: Salter Labs.

Clearance details

Applicant: Salter Labs
Product code: Code BZD
Advisory panel: Anesthesiology
Date received: 1991-06-03
Decision date: 1991-07-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Arvin, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code BZD

product code BZD

Death: 4,440
Injury: 53,099
Malfunction: 213,222
Other: 17
Total: 270,778

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.